Adam Tomasz Polonek
Corporate Officer/Principal bei BIOTON S.A.
Aktive Positionen von Adam Tomasz Polonek
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOTON S.A. | Corporate Officer/Principal | 20.12.2011 | - |
Finanzdirektor/CFO | 01.01.2006 | 20.12.2011 | |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Direktor/Vorstandsmitglied | - | - |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Vorsitzender | - | - |
Karriereverlauf von Adam Tomasz Polonek
Ehemalige bekannte Positionen von Adam Tomasz Polonek
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCIGEN LIMITED | Direktor/Vorstandsmitglied | 28.06.2008 | 07.08.2018 |
Finanzdirektor/CFO | 01.01.2013 | 31.08.2018 | |
Unternehmenssekretär | 01.07.2017 | 07.08.2018 | |
Caib Financial Advisers | Corporate Officer/Principal | 01.01.2000 | 01.01.2006 |
Ausbildung von Adam Tomasz Polonek
Uniwersytet Ekonomiczny w Katowicach | Undergraduate Degree |
Statistik
International
Polen | 4 |
Singapur | 2 |
Indien | 2 |
Operativ
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOTON S.A. | Health Technology |
Private Unternehmen | 4 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Health Technology |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Caib Financial Advisers |
- Börse
- Insiders
- Adam Tomasz Polonek
- Erfahrung